KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.3880
+0.0080 (2.11%)
At close: Mar 2, 2026, 4:00 PM EST
0.3920
+0.0040 (1.03%)
After-hours: Mar 2, 2026, 6:07 PM EST
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $10.96 million as of March 2, 2026. Its market cap has decreased by -68.04% in one year.
Market Cap
10.96M
Enterprise Value
19.81M
1-Year Change
-68.04%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $10.96M, a decrease of -97.45%. That is a compound annual growth rate of -34.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.10M | -32.61% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 11.90M |
| Longeveron | 11.55M |
| Chemomab Therapeutics | 11.45M |
| Liminatus Pharma | 11.35M |
| Imunon | 11.05M |
| Pulmatrix | 10.92M |
| Akari Therapeutics, | 10.69M |
| OSR Holdings | 10.58M |